Tourmaline Bio Highlights Cardiovascular Inflammation Focus and Announces Key Clinical and Strategic Updates at Investor Day
10 déc. 2024 08h30 HE
|
Tourmaline Bio, Inc.
Tourmaline Bio Highlights Cardiovascular Inflammation Focus and Announces Key Clinical and Strategic Updates at Investor Day
Tourmaline Bio to Host Investor Day on Tuesday, December 10, 2024
14 nov. 2024 07h30 HE
|
Tourmaline Bio, Inc.
Tourmaline Bio to Host Investor Day on Tuesday, December 10, 2024
Tourmaline Bio Reports Third Quarter 2024 Financial Results and Recent Business Highlights
07 nov. 2024 07h30 HE
|
Tourmaline Bio, Inc.
Tourmaline Bio Reports Third Quarter 2024 Financial Results and Recent Business Highlights
Tourmaline Bio to Present at Upcoming Investor Conferences
31 oct. 2024 07h30 HE
|
Tourmaline Bio, Inc.
Tourmaline Bio to Present at Upcoming Investor Conferences
Tourmaline Bio to Host Expert Webinar on Human Genetic Validation for IL-6 Inhibition in Cardiovascular Disease with Dr. Dipender Gill on Friday, November 1, 2024
15 oct. 2024 07h30 HE
|
Tourmaline Bio, Inc.
Tourmaline Bio to Host Expert Webinar on Human Genetic Validation for IL-6 Inhibition in Cardiovascular Disease with Dr. Dipender Gill on Friday, November
Tourmaline Bio to Showcase Two Poster Presentations at the 2024 Cardiometabolic Health Congress
11 oct. 2024 07h30 HE
|
Tourmaline Bio, Inc.
Tourmaline Bio to Showcase Two Poster Presentations at the 2024 Cardiometabolic Health Congress
Tourmaline Bio Announces Formation of Cardiovascular Scientific Advisory Board
08 oct. 2024 07h30 HE
|
Tourmaline Bio, Inc.
Tourmaline Bio Announces Formation of Cardiovascular Scientific Advisory Board
Tourmaline Bio to Present at Upcoming Investor Conferences
03 sept. 2024 07h45 HE
|
Tourmaline Bio, Inc.
Tourmaline Bio to Present at Upcoming Investor Conferences
Tourmaline Bio Reports Second Quarter 2024 Financial Results and Recent Business Highlights
08 août 2024 07h30 HE
|
Tourmaline Bio, Inc.
Tourmaline Bio Reports Second Quarter 2024 Financial Results and Recent Business Highlights
Tourmaline Bio Presents Phase 2 TRANQUILITY Study Design at American Society of Preventive Cardiology (ASPC) Congress 2024
02 août 2024 16h30 HE
|
Tourmaline Bio, Inc.
Tourmaline Bio Presents Phase 2 TRANQUILITY Study Design at American Society of Preventive Cardiology (ASPC) Congress 2024